These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23236561)

  • 21. Value of distinguishing differentiated thyroid carcinoma by miRNA.
    Xu J; Zhang D; Niu Q; Nan Y; Shi C; Zhao H; Liang X
    Oncol Lett; 2016 Jul; 12(1):79-82. PubMed ID: 27347103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA involvement in the pathogenesis and management of breast cancer.
    Khoshnaw SM; Green AR; Powe DG; Ellis IO
    J Clin Pathol; 2009 May; 62(5):422-8. PubMed ID: 19398594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA: The Potential Regulator of Endometrial Carcinogenesis.
    Kontomanolis EN; Koukourakis MI
    Microrna; 2015; 4(1):18-25. PubMed ID: 26088599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical pathological impacts of microRNAs in papillary thyroid carcinoma: A crucial review.
    Chruścik A; Lam AK
    Exp Mol Pathol; 2015 Dec; 99(3):393-8. PubMed ID: 26321247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic microRNA strategies in human cancer.
    Li C; Feng Y; Coukos G; Zhang L
    AAPS J; 2009 Dec; 11(4):747-57. PubMed ID: 19876744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer.
    Vriens MR; Weng J; Suh I; Huynh N; Guerrero MA; Shen WT; Duh QY; Clark OH; Kebebew E
    Cancer; 2012 Jul; 118(13):3426-32. PubMed ID: 22006248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary MicroRNAs as Emerging Class of Noninvasive Biomarkers.
    Juracek J; Slaby O
    Methods Mol Biol; 2020; 2115():221-247. PubMed ID: 32006404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNAs in inflammatory bowel disease--pathogenesis, diagnostics and therapeutics.
    Coskun M; Bjerrum JT; Seidelin JB; Nielsen OH
    World J Gastroenterol; 2012 Sep; 18(34):4629-34. PubMed ID: 23002331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating microRNA expression profiles in ovarian cancer.
    Ayaz L; Çayan F; Balci Ş; Görür A; Akbayir S; Yıldırım Yaroğlu H; Doğruer Unal N; Tamer L
    J Obstet Gynaecol; 2014 Oct; 34(7):620-4. PubMed ID: 24911418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a microRNA-based molecular assay for the detection of papillary thyroid carcinoma in aspiration biopsy samples.
    Mazeh H; Mizrahi I; Halle D; Ilyayev N; Stojadinovic A; Trink B; Mitrani-Rosenbaum S; Roistacher M; Ariel I; Eid A; Freund HR; Nissan A
    Thyroid; 2011 Feb; 21(2):111-8. PubMed ID: 21275764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA dysregulation in gastric cancer.
    Pan HW; Li SC; Tsai KW
    Curr Pharm Des; 2013; 19(7):1273-84. PubMed ID: 23092346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA: potential targets for the development of novel drugs?
    Wu W
    Drugs R D; 2010; 10(1):1-8. PubMed ID: 20509710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum miRNAs as Biomarkers for the Diagnosis and Prognosis of Thyroid Cancer: A Comprehensive Review of the Literature.
    Mahmoudian-Sani MR; Mehri-Ghahfarrokhi A; Asadi-Samani M; Mobini GR
    Eur Thyroid J; 2017 Jul; 6(4):171-177. PubMed ID: 28868257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of microRNA deregulation in human cancer.
    Deng S; Calin GA; Croce CM; Coukos G; Zhang L
    Cell Cycle; 2008 Sep; 7(17):2643-6. PubMed ID: 18719391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears.
    Fassina A; Cappellesso R; Simonato F; Siri M; Ventura L; Tosato F; Busund LT; Pelizzo MR; Fassan M
    Cancer Cytopathol; 2014 Apr; 122(4):274-81. PubMed ID: 24327568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. microRNA Therapeutics in Cancer - An Emerging Concept.
    Shah MY; Ferrajoli A; Sood AK; Lopez-Berestein G; Calin GA
    EBioMedicine; 2016 Oct; 12():34-42. PubMed ID: 27720213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The roles of microRNA in cancer and apoptosis.
    Lynam-Lennon N; Maher SG; Reynolds JV
    Biol Rev Camb Philos Soc; 2009 Feb; 84(1):55-71. PubMed ID: 19046400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression profile of MicroRNA: An Emerging Hallmark of Cancer.
    Zaheer U; Faheem M; Qadri I; Begum N; Yassine HM; Al Thani AA; Mathew S
    Curr Pharm Des; 2019; 25(6):642-653. PubMed ID: 30914015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. microRNAs as oncogenes and tumor suppressors.
    Zhang B; Pan X; Cobb GP; Anderson TA
    Dev Biol; 2007 Feb; 302(1):1-12. PubMed ID: 16989803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Micro-RNAs in thyroid neoplasms: molecular, diagnostic and therapeutic implications.
    Menon MP; Khan A
    J Clin Pathol; 2009 Nov; 62(11):978-85. PubMed ID: 19625289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.